nodes	percent_of_prediction	percent_of_DWPC	metapath
Zidovudine—TERT—skin cancer	0.475	1	CbGaD
Zidovudine—ABCC5—Fluorouracil—skin cancer	0.0493	0.12	CbGbCtD
Zidovudine—ABCG2—Vismodegib—skin cancer	0.0358	0.0876	CbGbCtD
Zidovudine—ABCG2—Vemurafenib—skin cancer	0.0283	0.0692	CbGbCtD
Zidovudine—ALB—Vismodegib—skin cancer	0.0247	0.0604	CbGbCtD
Zidovudine—SLC22A7—Fluorouracil—skin cancer	0.0242	0.0592	CbGbCtD
Zidovudine—ABCC4—Fluorouracil—skin cancer	0.0237	0.0578	CbGbCtD
Zidovudine—ALB—Vemurafenib—skin cancer	0.0195	0.0477	CbGbCtD
Zidovudine—CYP2C8—Vismodegib—skin cancer	0.0191	0.0466	CbGbCtD
Zidovudine—ABCG2—Dactinomycin—skin cancer	0.0188	0.046	CbGbCtD
Zidovudine—SLC22A7—Docetaxel—skin cancer	0.0185	0.0452	CbGbCtD
Zidovudine—CYP2C19—Vismodegib—skin cancer	0.016	0.0391	CbGbCtD
Zidovudine—CYP2A6—Fluorouracil—skin cancer	0.0137	0.0336	CbGbCtD
Zidovudine—CYP2C9—Vismodegib—skin cancer	0.0133	0.0325	CbGbCtD
Zidovudine—ABCB1—Vismodegib—skin cancer	0.0129	0.0316	CbGbCtD
Zidovudine—ABCG2—Fluorouracil—skin cancer	0.0127	0.0311	CbGbCtD
Zidovudine—CYP3A4—Imiquimod—skin cancer	0.0112	0.0273	CbGbCtD
Zidovudine—CYP3A4—Temozolomide—skin cancer	0.0112	0.0273	CbGbCtD
Zidovudine—ABCG2—Docetaxel—skin cancer	0.00972	0.0238	CbGbCtD
Zidovudine—ALB—Fluorouracil—skin cancer	0.00877	0.0214	CbGbCtD
Zidovudine—CYP3A4—Vismodegib—skin cancer	0.00774	0.0189	CbGbCtD
Zidovudine—ABCB1—Dactinomycin—skin cancer	0.00679	0.0166	CbGbCtD
Zidovudine—CYP2C8—Fluorouracil—skin cancer	0.00678	0.0166	CbGbCtD
Zidovudine—CYP3A4—Vemurafenib—skin cancer	0.00612	0.015	CbGbCtD
Zidovudine—CYP2C9—Fluorouracil—skin cancer	0.00473	0.0116	CbGbCtD
Zidovudine—ABCB1—Docetaxel—skin cancer	0.0035	0.00856	CbGbCtD
Zidovudine—CYP3A4—Docetaxel—skin cancer	0.0021	0.00513	CbGbCtD
Zidovudine—TERT—connective tissue—skin cancer	0.00153	0.0781	CbGeAlD
Zidovudine—TK1—nipple—skin cancer	0.00148	0.0758	CbGeAlD
Zidovudine—TERT—epithelium—skin cancer	0.00145	0.0741	CbGeAlD
Zidovudine—TERT—skin of body—skin cancer	0.00138	0.0705	CbGeAlD
Zidovudine—TK1—Fluoropyrimidine Activity—XRCC3—skin cancer	0.00135	0.111	CbGpPWpGaD
Zidovudine—TERT—lymphoid tissue—skin cancer	0.00112	0.0571	CbGeAlD
Zidovudine—TERT—female reproductive system—skin cancer	0.00108	0.0551	CbGeAlD
Zidovudine—TK1—epithelium—skin cancer	0.000999	0.051	CbGeAlD
Zidovudine—ABCC5—hair follicle—skin cancer	0.000978	0.0499	CbGeAlD
Zidovudine—TK1—skin of body—skin cancer	0.000951	0.0485	CbGeAlD
Zidovudine—TERT—head—skin cancer	0.000901	0.046	CbGeAlD
Zidovudine—TK1—mammalian vulva—skin cancer	0.000867	0.0442	CbGeAlD
Zidovudine—TERT—HIF-1-alpha transcription factor network—PLIN2—skin cancer	0.000775	0.0638	CbGpPWpGaD
Zidovudine—TK1—lymphoid tissue—skin cancer	0.00077	0.0393	CbGeAlD
Zidovudine—TK1—female reproductive system—skin cancer	0.000742	0.0379	CbGeAlD
Zidovudine—TK1—head—skin cancer	0.00062	0.0317	CbGeAlD
Zidovudine—SLC29A2—female reproductive system—skin cancer	0.000614	0.0313	CbGeAlD
Zidovudine—ABCC5—Fluoropyrimidine Activity—XRCC3—skin cancer	0.000537	0.0442	CbGpPWpGaD
Zidovudine—TK1—E2F transcription factor network—XRCC1—skin cancer	0.000519	0.0427	CbGpPWpGaD
Zidovudine—TK1—Fluoropyrimidine Activity—ERCC2—skin cancer	0.000475	0.0391	CbGpPWpGaD
Zidovudine—SLC22A7—Fluoropyrimidine Activity—XRCC3—skin cancer	0.000462	0.038	CbGpPWpGaD
Zidovudine—TK1—lymph node—skin cancer	0.000434	0.0222	CbGeAlD
Zidovudine—UGT2B7—female reproductive system—skin cancer	0.000415	0.0212	CbGeAlD
Zidovudine—TERT—Regulation of nuclear beta catenin signaling and target gene transcription—MITF—skin cancer	0.000406	0.0334	CbGpPWpGaD
Zidovudine—SLC22A11—female reproductive system—skin cancer	0.000404	0.0206	CbGeAlD
Zidovudine—ABCC4—Fluoropyrimidine Activity—XRCC3—skin cancer	0.000372	0.0306	CbGpPWpGaD
Zidovudine—SLC29A2—lymph node—skin cancer	0.000359	0.0183	CbGeAlD
Zidovudine—SLC28A1—SLC-mediated transmembrane transport—SLC12A2—skin cancer	0.000288	0.0237	CbGpPWpGaD
Zidovudine—ABCG2—Fluoropyrimidine Activity—XRCC3—skin cancer	0.000273	0.0225	CbGpPWpGaD
Zidovudine—CYP2A6—Fluoropyrimidine Activity—XRCC3—skin cancer	0.000248	0.0204	CbGpPWpGaD
Zidovudine—SLC29A2—SLC-mediated transmembrane transport—SLC12A2—skin cancer	0.000235	0.0194	CbGpPWpGaD
Zidovudine—ABCC4—female reproductive system—skin cancer	0.00023	0.0117	CbGeAlD
Zidovudine—ABCB1—blood vessel—skin cancer	0.000221	0.0113	CbGeAlD
Zidovudine—TK1—Validated targets of C-MYC transcriptional activation—TERT—skin cancer	0.000221	0.0182	CbGpPWpGaD
Zidovudine—TK1—Validated targets of C-MYC transcriptional activation—CDK4—skin cancer	0.000198	0.0163	CbGpPWpGaD
Zidovudine—ABCC5—lymph node—skin cancer	0.000194	0.0099	CbGeAlD
Zidovudine—ABCC4—head—skin cancer	0.000192	0.0098	CbGeAlD
Zidovudine—SLC22A8—head—skin cancer	0.000191	0.00972	CbGeAlD
Zidovudine—ABCG2—mammalian vulva—skin cancer	0.000189	0.00967	CbGeAlD
Zidovudine—ABCC5—Fluoropyrimidine Activity—ERCC2—skin cancer	0.000189	0.0156	CbGpPWpGaD
Zidovudine—TERT—Validated targets of C-MYC transcriptional activation—CDK4—skin cancer	0.000179	0.0147	CbGpPWpGaD
Zidovudine—ABCG2—HIF-1-alpha transcription factor network—PLIN2—skin cancer	0.000173	0.0143	CbGpPWpGaD
Zidovudine—ABCC5—Defective B3GAT3 causes JDSSDHD—CSPG4—skin cancer	0.000171	0.0141	CbGpPWpGaD
Zidovudine—TK1—Fluoropyrimidine Activity—TP53—skin cancer	0.000169	0.0139	CbGpPWpGaD
Zidovudine—CYP2C8—female reproductive system—skin cancer	0.000167	0.00852	CbGeAlD
Zidovudine—SLC22A7—Fluoropyrimidine Activity—ERCC2—skin cancer	0.000163	0.0134	CbGpPWpGaD
Zidovudine—TK1—E2F transcription factor network—CDKN2A—skin cancer	0.000161	0.0133	CbGpPWpGaD
Zidovudine—Fatigue—Imiquimod—skin cancer	0.00016	0.00191	CcSEcCtD
Zidovudine—Pain—Imiquimod—skin cancer	0.000159	0.0019	CcSEcCtD
Zidovudine—Neuropathy peripheral—Fluorouracil—skin cancer	0.000158	0.00188	CcSEcCtD
Zidovudine—Stomatitis—Fluorouracil—skin cancer	0.000157	0.00187	CcSEcCtD
Zidovudine—Hepatitis—Temozolomide—skin cancer	0.000157	0.00187	CcSEcCtD
Zidovudine—Asthenia—Vemurafenib—skin cancer	0.000156	0.00186	CcSEcCtD
Zidovudine—Pharyngitis—Temozolomide—skin cancer	0.000156	0.00186	CcSEcCtD
Zidovudine—Chills—Dactinomycin—skin cancer	0.000156	0.00185	CcSEcCtD
Zidovudine—Urinary tract disorder—Temozolomide—skin cancer	0.000155	0.00185	CcSEcCtD
Zidovudine—Pruritus—Vemurafenib—skin cancer	0.000154	0.00184	CcSEcCtD
Zidovudine—Connective tissue disorder—Temozolomide—skin cancer	0.000154	0.00184	CcSEcCtD
Zidovudine—Urethral disorder—Temozolomide—skin cancer	0.000154	0.00183	CcSEcCtD
Zidovudine—Feeling abnormal—Imiquimod—skin cancer	0.000153	0.00183	CcSEcCtD
Zidovudine—Gastrointestinal pain—Imiquimod—skin cancer	0.000152	0.00181	CcSEcCtD
Zidovudine—Epistaxis—Fluorouracil—skin cancer	0.000152	0.00181	CcSEcCtD
Zidovudine—Sinusitis—Fluorouracil—skin cancer	0.000151	0.0018	CcSEcCtD
Zidovudine—Erythema—Dactinomycin—skin cancer	0.000151	0.0018	CcSEcCtD
Zidovudine—Agranulocytosis—Fluorouracil—skin cancer	0.00015	0.00179	CcSEcCtD
Zidovudine—Ill-defined disorder—Bleomycin—skin cancer	0.00015	0.00179	CcSEcCtD
Zidovudine—Anaemia—Bleomycin—skin cancer	0.00015	0.00178	CcSEcCtD
Zidovudine—Diarrhoea—Vemurafenib—skin cancer	0.000149	0.00178	CcSEcCtD
Zidovudine—CYP2C9—female reproductive system—skin cancer	0.000148	0.00756	CbGeAlD
Zidovudine—Erythema multiforme—Temozolomide—skin cancer	0.000148	0.00177	CcSEcCtD
Zidovudine—Urticaria—Imiquimod—skin cancer	0.000148	0.00176	CcSEcCtD
Zidovudine—Body temperature increased—Imiquimod—skin cancer	0.000147	0.00175	CcSEcCtD
Zidovudine—Abdominal pain—Imiquimod—skin cancer	0.000147	0.00175	CcSEcCtD
Zidovudine—SLC28A1—Transmembrane transport of small molecules—SLC12A2—skin cancer	0.000147	0.0121	CbGpPWpGaD
Zidovudine—Malaise—Bleomycin—skin cancer	0.000146	0.00174	CcSEcCtD
Zidovudine—Cardiac disorder—Temozolomide—skin cancer	0.000145	0.00174	CcSEcCtD
Zidovudine—Leukopenia—Bleomycin—skin cancer	0.000145	0.00173	CcSEcCtD
Zidovudine—Rhinitis—Fluorouracil—skin cancer	0.000145	0.00173	CcSEcCtD
Zidovudine—Dizziness—Vemurafenib—skin cancer	0.000144	0.00172	CcSEcCtD
Zidovudine—Pharyngitis—Fluorouracil—skin cancer	0.000143	0.00171	CcSEcCtD
Zidovudine—Mediastinal disorder—Temozolomide—skin cancer	0.000141	0.00168	CcSEcCtD
Zidovudine—Cough—Bleomycin—skin cancer	0.000141	0.00168	CcSEcCtD
Zidovudine—Chills—Temozolomide—skin cancer	0.000141	0.00168	CcSEcCtD
Zidovudine—ALB—FOXA2 and FOXA3 transcription factor networks—NKX2-1—skin cancer	0.00014	0.0115	CbGpPWpGaD
Zidovudine—Ill-defined disorder—Dactinomycin—skin cancer	0.00014	0.00167	CcSEcCtD
Zidovudine—Anaemia—Dactinomycin—skin cancer	0.000139	0.00166	CcSEcCtD
Zidovudine—ALB—lymph node—skin cancer	0.000139	0.00709	CbGeAlD
Zidovudine—Vomiting—Vemurafenib—skin cancer	0.000139	0.00165	CcSEcCtD
Zidovudine—Myalgia—Bleomycin—skin cancer	0.000138	0.00164	CcSEcCtD
Zidovudine—Chest pain—Bleomycin—skin cancer	0.000138	0.00164	CcSEcCtD
Zidovudine—Rash—Vemurafenib—skin cancer	0.000137	0.00164	CcSEcCtD
Zidovudine—Mental disorder—Temozolomide—skin cancer	0.000137	0.00164	CcSEcCtD
Zidovudine—Dermatitis—Vemurafenib—skin cancer	0.000137	0.00164	CcSEcCtD
Zidovudine—Headache—Vemurafenib—skin cancer	0.000137	0.00163	CcSEcCtD
Zidovudine—Malnutrition—Temozolomide—skin cancer	0.000136	0.00163	CcSEcCtD
Zidovudine—Erythema—Temozolomide—skin cancer	0.000136	0.00163	CcSEcCtD
Zidovudine—Breast disorder—Docetaxel—skin cancer	0.000136	0.00162	CcSEcCtD
Zidovudine—Discomfort—Bleomycin—skin cancer	0.000136	0.00162	CcSEcCtD
Zidovudine—Malaise—Dactinomycin—skin cancer	0.000136	0.00162	CcSEcCtD
Zidovudine—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.000136	0.00162	CcSEcCtD
Zidovudine—Aspartate aminotransferase increased—Docetaxel—skin cancer	0.000136	0.00162	CcSEcCtD
Zidovudine—TERT—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—skin cancer	0.000136	0.0112	CbGpPWpGaD
Zidovudine—Leukopenia—Dactinomycin—skin cancer	0.000135	0.00161	CcSEcCtD
Zidovudine—Nasopharyngitis—Docetaxel—skin cancer	0.000135	0.00161	CcSEcCtD
Zidovudine—ABCC4—lymph node—skin cancer	0.000134	0.00686	CbGeAlD
Zidovudine—Dysgeusia—Temozolomide—skin cancer	0.000134	0.00159	CcSEcCtD
Zidovudine—Asthenia—Imiquimod—skin cancer	0.000133	0.00159	CcSEcCtD
Zidovudine—Confusional state—Bleomycin—skin cancer	0.000133	0.00159	CcSEcCtD
Zidovudine—Oedema—Bleomycin—skin cancer	0.000132	0.00157	CcSEcCtD
Zidovudine—Anaphylactic shock—Bleomycin—skin cancer	0.000132	0.00157	CcSEcCtD
Zidovudine—Back pain—Temozolomide—skin cancer	0.000132	0.00157	CcSEcCtD
Zidovudine—Pruritus—Imiquimod—skin cancer	0.000131	0.00157	CcSEcCtD
Zidovudine—ABCC4—Fluoropyrimidine Activity—ERCC2—skin cancer	0.000131	0.0108	CbGpPWpGaD
Zidovudine—Dysphagia—Docetaxel—skin cancer	0.00013	0.00155	CcSEcCtD
Zidovudine—Nausea—Vemurafenib—skin cancer	0.000129	0.00154	CcSEcCtD
Zidovudine—Thrombocytopenia—Bleomycin—skin cancer	0.000129	0.00154	CcSEcCtD
Zidovudine—Myalgia—Dactinomycin—skin cancer	0.000128	0.00153	CcSEcCtD
Zidovudine—Tremor—Temozolomide—skin cancer	0.000128	0.00152	CcSEcCtD
Zidovudine—Diarrhoea—Imiquimod—skin cancer	0.000127	0.00152	CcSEcCtD
Zidovudine—Discomfort—Dactinomycin—skin cancer	0.000127	0.00151	CcSEcCtD
Zidovudine—Ill-defined disorder—Temozolomide—skin cancer	0.000127	0.00151	CcSEcCtD
Zidovudine—Anaemia—Temozolomide—skin cancer	0.000126	0.0015	CcSEcCtD
Zidovudine—Anorexia—Bleomycin—skin cancer	0.000126	0.0015	CcSEcCtD
Zidovudine—Erythema—Fluorouracil—skin cancer	0.000126	0.0015	CcSEcCtD
Zidovudine—Angioedema—Temozolomide—skin cancer	0.000125	0.00149	CcSEcCtD
Zidovudine—Pancytopenia—Docetaxel—skin cancer	0.000124	0.00148	CcSEcCtD
Zidovudine—Oedema—Dactinomycin—skin cancer	0.000123	0.00147	CcSEcCtD
Zidovudine—Malaise—Temozolomide—skin cancer	0.000123	0.00147	CcSEcCtD
Zidovudine—Dizziness—Imiquimod—skin cancer	0.000123	0.00147	CcSEcCtD
Zidovudine—Vertigo—Temozolomide—skin cancer	0.000123	0.00146	CcSEcCtD
Zidovudine—Leukopenia—Temozolomide—skin cancer	0.000122	0.00146	CcSEcCtD
Zidovudine—Neutropenia—Docetaxel—skin cancer	0.000122	0.00145	CcSEcCtD
Zidovudine—Thrombocytopenia—Dactinomycin—skin cancer	0.000121	0.00144	CcSEcCtD
Zidovudine—Musculoskeletal discomfort—Bleomycin—skin cancer	0.00012	0.00143	CcSEcCtD
Zidovudine—SLC29A2—Transmembrane transport of small molecules—SLC12A2—skin cancer	0.000119	0.00984	CbGpPWpGaD
Zidovudine—Cough—Temozolomide—skin cancer	0.000119	0.00142	CcSEcCtD
Zidovudine—Paraesthesia—Bleomycin—skin cancer	0.000119	0.00141	CcSEcCtD
Zidovudine—Convulsion—Temozolomide—skin cancer	0.000118	0.00141	CcSEcCtD
Zidovudine—Vomiting—Imiquimod—skin cancer	0.000118	0.00141	CcSEcCtD
Zidovudine—Weight decreased—Docetaxel—skin cancer	0.000118	0.00141	CcSEcCtD
Zidovudine—Dyspnoea—Bleomycin—skin cancer	0.000118	0.0014	CcSEcCtD
Zidovudine—Anorexia—Dactinomycin—skin cancer	0.000117	0.0014	CcSEcCtD
Zidovudine—Rash—Imiquimod—skin cancer	0.000117	0.0014	CcSEcCtD
Zidovudine—Dermatitis—Imiquimod—skin cancer	0.000117	0.0014	CcSEcCtD
Zidovudine—Headache—Imiquimod—skin cancer	0.000116	0.00139	CcSEcCtD
Zidovudine—Anaemia—Fluorouracil—skin cancer	0.000116	0.00139	CcSEcCtD
Zidovudine—Myalgia—Temozolomide—skin cancer	0.000116	0.00139	CcSEcCtD
Zidovudine—Arthralgia—Temozolomide—skin cancer	0.000116	0.00139	CcSEcCtD
Zidovudine—Anxiety—Temozolomide—skin cancer	0.000116	0.00138	CcSEcCtD
Zidovudine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000115	0.00138	CcSEcCtD
Zidovudine—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.000115	0.00137	CcSEcCtD
Zidovudine—Discomfort—Temozolomide—skin cancer	0.000115	0.00137	CcSEcCtD
Zidovudine—Decreased appetite—Bleomycin—skin cancer	0.000115	0.00137	CcSEcCtD
Zidovudine—Neuropathy peripheral—Docetaxel—skin cancer	0.000114	0.00136	CcSEcCtD
Zidovudine—Jaundice—Docetaxel—skin cancer	0.000113	0.00135	CcSEcCtD
Zidovudine—Stomatitis—Docetaxel—skin cancer	0.000113	0.00135	CcSEcCtD
Zidovudine—CYP3A4—female reproductive system—skin cancer	0.000113	0.00577	CbGeAlD
Zidovudine—Pain—Bleomycin—skin cancer	0.000113	0.00135	CcSEcCtD
Zidovudine—Leukopenia—Fluorouracil—skin cancer	0.000113	0.00134	CcSEcCtD
Zidovudine—Confusional state—Temozolomide—skin cancer	0.000112	0.00134	CcSEcCtD
Zidovudine—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000112	0.00134	CcSEcCtD
Zidovudine—TERT—Signaling Pathways—RHOU—skin cancer	0.000112	0.00923	CbGpPWpGaD
Zidovudine—Oedema—Temozolomide—skin cancer	0.000111	0.00133	CcSEcCtD
Zidovudine—Anaphylactic shock—Temozolomide—skin cancer	0.000111	0.00133	CcSEcCtD
Zidovudine—Nausea—Imiquimod—skin cancer	0.00011	0.00132	CcSEcCtD
Zidovudine—Hepatobiliary disease—Docetaxel—skin cancer	0.00011	0.00131	CcSEcCtD
Zidovudine—Epistaxis—Docetaxel—skin cancer	0.00011	0.00131	CcSEcCtD
Zidovudine—Nervous system disorder—Temozolomide—skin cancer	0.000109	0.0013	CcSEcCtD
Zidovudine—Thrombocytopenia—Temozolomide—skin cancer	0.000109	0.0013	CcSEcCtD
Zidovudine—Convulsion—Fluorouracil—skin cancer	0.000109	0.0013	CcSEcCtD
Zidovudine—Feeling abnormal—Bleomycin—skin cancer	0.000109	0.0013	CcSEcCtD
Zidovudine—Agranulocytosis—Docetaxel—skin cancer	0.000108	0.00129	CcSEcCtD
Zidovudine—Skin disorder—Temozolomide—skin cancer	0.000108	0.00129	CcSEcCtD
Zidovudine—ABCB1—epithelium—skin cancer	0.000108	0.0055	CbGeAlD
Zidovudine—Hyperhidrosis—Temozolomide—skin cancer	0.000108	0.00128	CcSEcCtD
Zidovudine—Chest pain—Fluorouracil—skin cancer	0.000107	0.00128	CcSEcCtD
Zidovudine—Myalgia—Fluorouracil—skin cancer	0.000107	0.00128	CcSEcCtD
Zidovudine—Decreased appetite—Dactinomycin—skin cancer	0.000107	0.00128	CcSEcCtD
Zidovudine—Fatigue—Dactinomycin—skin cancer	0.000106	0.00127	CcSEcCtD
Zidovudine—Anorexia—Temozolomide—skin cancer	0.000106	0.00127	CcSEcCtD
Zidovudine—Discomfort—Fluorouracil—skin cancer	0.000106	0.00126	CcSEcCtD
Zidovudine—Pain—Dactinomycin—skin cancer	0.000105	0.00126	CcSEcCtD
Zidovudine—Urticaria—Bleomycin—skin cancer	0.000105	0.00125	CcSEcCtD
Zidovudine—Rhinitis—Docetaxel—skin cancer	0.000105	0.00125	CcSEcCtD
Zidovudine—Body temperature increased—Bleomycin—skin cancer	0.000104	0.00124	CcSEcCtD
Zidovudine—Hepatitis—Docetaxel—skin cancer	0.000104	0.00124	CcSEcCtD
Zidovudine—Confusional state—Fluorouracil—skin cancer	0.000103	0.00123	CcSEcCtD
Zidovudine—Pharyngitis—Docetaxel—skin cancer	0.000103	0.00123	CcSEcCtD
Zidovudine—Urinary tract disorder—Docetaxel—skin cancer	0.000103	0.00123	CcSEcCtD
Zidovudine—Anaphylactic shock—Fluorouracil—skin cancer	0.000103	0.00122	CcSEcCtD
Zidovudine—Oedema—Fluorouracil—skin cancer	0.000103	0.00122	CcSEcCtD
Zidovudine—Connective tissue disorder—Docetaxel—skin cancer	0.000102	0.00122	CcSEcCtD
Zidovudine—SLC22A11—SLC-mediated transmembrane transport—SLC12A2—skin cancer	0.000102	0.00842	CbGpPWpGaD
Zidovudine—Urethral disorder—Docetaxel—skin cancer	0.000102	0.00122	CcSEcCtD
Zidovudine—Feeling abnormal—Dactinomycin—skin cancer	0.000101	0.00121	CcSEcCtD
Zidovudine—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000101	0.00121	CcSEcCtD
Zidovudine—Insomnia—Temozolomide—skin cancer	0.000101	0.0012	CcSEcCtD
Zidovudine—Gastrointestinal pain—Dactinomycin—skin cancer	0.000101	0.0012	CcSEcCtD
Zidovudine—Nervous system disorder—Fluorouracil—skin cancer	0.000101	0.0012	CcSEcCtD
Zidovudine—Thrombocytopenia—Fluorouracil—skin cancer	0.0001	0.0012	CcSEcCtD
Zidovudine—Paraesthesia—Temozolomide—skin cancer	0.0001	0.00119	CcSEcCtD
Zidovudine—Dyspnoea—Temozolomide—skin cancer	9.93e-05	0.00118	CcSEcCtD
Zidovudine—Somnolence—Temozolomide—skin cancer	9.9e-05	0.00118	CcSEcCtD
Zidovudine—Erythema multiforme—Docetaxel—skin cancer	9.86e-05	0.00118	CcSEcCtD
Zidovudine—Dyspepsia—Temozolomide—skin cancer	9.8e-05	0.00117	CcSEcCtD
Zidovudine—Anorexia—Fluorouracil—skin cancer	9.78e-05	0.00117	CcSEcCtD
Zidovudine—Abdominal pain—Dactinomycin—skin cancer	9.73e-05	0.00116	CcSEcCtD
Zidovudine—Body temperature increased—Dactinomycin—skin cancer	9.73e-05	0.00116	CcSEcCtD
Zidovudine—Decreased appetite—Temozolomide—skin cancer	9.68e-05	0.00115	CcSEcCtD
Zidovudine—Cardiac disorder—Docetaxel—skin cancer	9.68e-05	0.00115	CcSEcCtD
Zidovudine—Gastrointestinal disorder—Temozolomide—skin cancer	9.62e-05	0.00115	CcSEcCtD
Zidovudine—ABCG2—Fluoropyrimidine Activity—ERCC2—skin cancer	9.6e-05	0.00791	CbGpPWpGaD
Zidovudine—Fatigue—Temozolomide—skin cancer	9.6e-05	0.00115	CcSEcCtD
Zidovudine—Constipation—Temozolomide—skin cancer	9.52e-05	0.00114	CcSEcCtD
Zidovudine—Pain—Temozolomide—skin cancer	9.52e-05	0.00114	CcSEcCtD
Zidovudine—ABCG2—lymph node—skin cancer	9.49e-05	0.00484	CbGeAlD
Zidovudine—Asthenia—Bleomycin—skin cancer	9.47e-05	0.00113	CcSEcCtD
Zidovudine—Mediastinal disorder—Docetaxel—skin cancer	9.4e-05	0.00112	CcSEcCtD
Zidovudine—ABCB1—HIF-1-alpha transcription factor network—PLIN2—skin cancer	9.37e-05	0.00771	CbGpPWpGaD
Zidovudine—Chills—Docetaxel—skin cancer	9.35e-05	0.00112	CcSEcCtD
Zidovudine—Musculoskeletal discomfort—Fluorouracil—skin cancer	9.35e-05	0.00111	CcSEcCtD
Zidovudine—ABCB1—mammalian vulva—skin cancer	9.34e-05	0.00477	CbGeAlD
Zidovudine—Pruritus—Bleomycin—skin cancer	9.34e-05	0.00111	CcSEcCtD
Zidovudine—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—skin cancer	9.34e-05	0.00769	CbGpPWpGaD
Zidovudine—SLC22A7—SLC-mediated transmembrane transport—SLC12A2—skin cancer	9.28e-05	0.00764	CbGpPWpGaD
Zidovudine—Insomnia—Fluorouracil—skin cancer	9.28e-05	0.00111	CcSEcCtD
Zidovudine—Paraesthesia—Fluorouracil—skin cancer	9.21e-05	0.0011	CcSEcCtD
Zidovudine—ABCC5—Carbohydrate metabolism—CSPG4—skin cancer	9.21e-05	0.00758	CbGpPWpGaD
Zidovudine—Feeling abnormal—Temozolomide—skin cancer	9.18e-05	0.00109	CcSEcCtD
Zidovudine—Dyspnoea—Fluorouracil—skin cancer	9.15e-05	0.00109	CcSEcCtD
Zidovudine—Mental disorder—Docetaxel—skin cancer	9.13e-05	0.00109	CcSEcCtD
Zidovudine—Somnolence—Fluorouracil—skin cancer	9.12e-05	0.00109	CcSEcCtD
Zidovudine—Gastrointestinal pain—Temozolomide—skin cancer	9.11e-05	0.00109	CcSEcCtD
Zidovudine—Malnutrition—Docetaxel—skin cancer	9.08e-05	0.00108	CcSEcCtD
Zidovudine—Erythema—Docetaxel—skin cancer	9.08e-05	0.00108	CcSEcCtD
Zidovudine—Dyspepsia—Fluorouracil—skin cancer	9.03e-05	0.00108	CcSEcCtD
Zidovudine—Decreased appetite—Fluorouracil—skin cancer	8.92e-05	0.00106	CcSEcCtD
Zidovudine—Dysgeusia—Docetaxel—skin cancer	8.89e-05	0.00106	CcSEcCtD
Zidovudine—Gastrointestinal disorder—Fluorouracil—skin cancer	8.86e-05	0.00106	CcSEcCtD
Zidovudine—Urticaria—Temozolomide—skin cancer	8.85e-05	0.00106	CcSEcCtD
Zidovudine—Asthenia—Dactinomycin—skin cancer	8.84e-05	0.00105	CcSEcCtD
Zidovudine—Body temperature increased—Temozolomide—skin cancer	8.8e-05	0.00105	CcSEcCtD
Zidovudine—Abdominal pain—Temozolomide—skin cancer	8.8e-05	0.00105	CcSEcCtD
Zidovudine—Back pain—Docetaxel—skin cancer	8.78e-05	0.00105	CcSEcCtD
Zidovudine—Pain—Fluorouracil—skin cancer	8.78e-05	0.00105	CcSEcCtD
Zidovudine—Muscle spasms—Docetaxel—skin cancer	8.73e-05	0.00104	CcSEcCtD
Zidovudine—CYP2A6—Fluoropyrimidine Activity—ERCC2—skin cancer	8.72e-05	0.00718	CbGpPWpGaD
Zidovudine—Feeling abnormal—Fluorouracil—skin cancer	8.46e-05	0.00101	CcSEcCtD
Zidovudine—Diarrhoea—Dactinomycin—skin cancer	8.43e-05	0.001	CcSEcCtD
Zidovudine—TK1—Validated targets of C-MYC transcriptional activation—TP53—skin cancer	8.42e-05	0.00694	CbGpPWpGaD
Zidovudine—Vomiting—Bleomycin—skin cancer	8.4e-05	0.001	CcSEcCtD
Zidovudine—Anaemia—Docetaxel—skin cancer	8.39e-05	0.001	CcSEcCtD
Zidovudine—Rash—Bleomycin—skin cancer	8.33e-05	0.000993	CcSEcCtD
Zidovudine—Dermatitis—Bleomycin—skin cancer	8.32e-05	0.000992	CcSEcCtD
Zidovudine—ABCB1—lymphoid tissue—skin cancer	8.3e-05	0.00423	CbGeAlD
Zidovudine—Urticaria—Fluorouracil—skin cancer	8.15e-05	0.000972	CcSEcCtD
Zidovudine—Syncope—Docetaxel—skin cancer	8.14e-05	0.000971	CcSEcCtD
Zidovudine—Leukopenia—Docetaxel—skin cancer	8.12e-05	0.000969	CcSEcCtD
Zidovudine—Body temperature increased—Fluorouracil—skin cancer	8.11e-05	0.000967	CcSEcCtD
Zidovudine—ABCB1—female reproductive system—skin cancer	8e-05	0.00408	CbGeAlD
Zidovudine—Asthenia—Temozolomide—skin cancer	7.99e-05	0.000953	CcSEcCtD
Zidovudine—Loss of consciousness—Docetaxel—skin cancer	7.98e-05	0.000951	CcSEcCtD
Zidovudine—Cough—Docetaxel—skin cancer	7.92e-05	0.000944	CcSEcCtD
Zidovudine—Pruritus—Temozolomide—skin cancer	7.88e-05	0.00094	CcSEcCtD
Zidovudine—Convulsion—Docetaxel—skin cancer	7.86e-05	0.000938	CcSEcCtD
Zidovudine—Nausea—Bleomycin—skin cancer	7.84e-05	0.000935	CcSEcCtD
Zidovudine—Vomiting—Dactinomycin—skin cancer	7.83e-05	0.000934	CcSEcCtD
Zidovudine—SLC22A8—SLC-mediated transmembrane transport—SLC12A2—skin cancer	7.8e-05	0.00642	CbGpPWpGaD
Zidovudine—Rash—Dactinomycin—skin cancer	7.76e-05	0.000926	CcSEcCtD
Zidovudine—Arthralgia—Docetaxel—skin cancer	7.73e-05	0.000921	CcSEcCtD
Zidovudine—Chest pain—Docetaxel—skin cancer	7.73e-05	0.000921	CcSEcCtD
Zidovudine—Myalgia—Docetaxel—skin cancer	7.73e-05	0.000921	CcSEcCtD
Zidovudine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	7.67e-05	0.000915	CcSEcCtD
Zidovudine—Diarrhoea—Temozolomide—skin cancer	7.62e-05	0.000909	CcSEcCtD
Zidovudine—TERT—Validated targets of C-MYC transcriptional activation—TP53—skin cancer	7.62e-05	0.00627	CbGpPWpGaD
Zidovudine—TERT—Cell Cycle—MLH1—skin cancer	7.53e-05	0.0062	CbGpPWpGaD
Zidovudine—Confusional state—Docetaxel—skin cancer	7.47e-05	0.000891	CcSEcCtD
Zidovudine—Oedema—Docetaxel—skin cancer	7.41e-05	0.000883	CcSEcCtD
Zidovudine—Anaphylactic shock—Docetaxel—skin cancer	7.41e-05	0.000883	CcSEcCtD
Zidovudine—Dizziness—Temozolomide—skin cancer	7.37e-05	0.000878	CcSEcCtD
Zidovudine—Nausea—Dactinomycin—skin cancer	7.31e-05	0.000872	CcSEcCtD
Zidovudine—Shock—Docetaxel—skin cancer	7.29e-05	0.000869	CcSEcCtD
Zidovudine—Nervous system disorder—Docetaxel—skin cancer	7.26e-05	0.000866	CcSEcCtD
Zidovudine—Pruritus—Fluorouracil—skin cancer	7.26e-05	0.000866	CcSEcCtD
Zidovudine—Thrombocytopenia—Docetaxel—skin cancer	7.25e-05	0.000865	CcSEcCtD
Zidovudine—Skin disorder—Docetaxel—skin cancer	7.19e-05	0.000858	CcSEcCtD
Zidovudine—ABCC4—Ectoderm Differentiation—SHH—skin cancer	7.18e-05	0.00591	CbGpPWpGaD
Zidovudine—Vomiting—Temozolomide—skin cancer	7.08e-05	0.000845	CcSEcCtD
Zidovudine—Anorexia—Docetaxel—skin cancer	7.06e-05	0.000842	CcSEcCtD
Zidovudine—Rash—Temozolomide—skin cancer	7.02e-05	0.000837	CcSEcCtD
Zidovudine—Diarrhoea—Fluorouracil—skin cancer	7.02e-05	0.000837	CcSEcCtD
Zidovudine—Dermatitis—Temozolomide—skin cancer	7.02e-05	0.000837	CcSEcCtD
Zidovudine—Headache—Temozolomide—skin cancer	6.98e-05	0.000832	CcSEcCtD
Zidovudine—TK1—Metabolism—PLIN2—skin cancer	6.81e-05	0.0056	CbGpPWpGaD
Zidovudine—Dizziness—Fluorouracil—skin cancer	6.79e-05	0.000809	CcSEcCtD
Zidovudine—Musculoskeletal discomfort—Docetaxel—skin cancer	6.75e-05	0.000805	CcSEcCtD
Zidovudine—ABCC5—Fluoropyrimidine Activity—TP53—skin cancer	6.74e-05	0.00555	CbGpPWpGaD
Zidovudine—Insomnia—Docetaxel—skin cancer	6.7e-05	0.000799	CcSEcCtD
Zidovudine—ABCB1—head—skin cancer	6.68e-05	0.00341	CbGeAlD
Zidovudine—Paraesthesia—Docetaxel—skin cancer	6.65e-05	0.000793	CcSEcCtD
Zidovudine—Nausea—Temozolomide—skin cancer	6.62e-05	0.000789	CcSEcCtD
Zidovudine—Dyspnoea—Docetaxel—skin cancer	6.6e-05	0.000788	CcSEcCtD
Zidovudine—Somnolence—Docetaxel—skin cancer	6.58e-05	0.000785	CcSEcCtD
Zidovudine—Vomiting—Fluorouracil—skin cancer	6.52e-05	0.000778	CcSEcCtD
Zidovudine—Dyspepsia—Docetaxel—skin cancer	6.52e-05	0.000778	CcSEcCtD
Zidovudine—SLC22A6—SLC-mediated transmembrane transport—SLC12A2—skin cancer	6.51e-05	0.00536	CbGpPWpGaD
Zidovudine—Rash—Fluorouracil—skin cancer	6.47e-05	0.000772	CcSEcCtD
Zidovudine—Dermatitis—Fluorouracil—skin cancer	6.46e-05	0.000771	CcSEcCtD
Zidovudine—Decreased appetite—Docetaxel—skin cancer	6.44e-05	0.000768	CcSEcCtD
Zidovudine—Headache—Fluorouracil—skin cancer	6.43e-05	0.000767	CcSEcCtD
Zidovudine—Gastrointestinal disorder—Docetaxel—skin cancer	6.39e-05	0.000763	CcSEcCtD
Zidovudine—Fatigue—Docetaxel—skin cancer	6.39e-05	0.000762	CcSEcCtD
Zidovudine—Pain—Docetaxel—skin cancer	6.33e-05	0.000755	CcSEcCtD
Zidovudine—Constipation—Docetaxel—skin cancer	6.33e-05	0.000755	CcSEcCtD
Zidovudine—ABCC5—Carbohydrate metabolism—ENO2—skin cancer	6.26e-05	0.00515	CbGpPWpGaD
Zidovudine—Feeling abnormal—Docetaxel—skin cancer	6.1e-05	0.000728	CcSEcCtD
Zidovudine—Nausea—Fluorouracil—skin cancer	6.1e-05	0.000727	CcSEcCtD
Zidovudine—Gastrointestinal pain—Docetaxel—skin cancer	6.06e-05	0.000722	CcSEcCtD
Zidovudine—TERT—Disease—CSPG4—skin cancer	5.92e-05	0.00488	CbGpPWpGaD
Zidovudine—Body temperature increased—Docetaxel—skin cancer	5.86e-05	0.000698	CcSEcCtD
Zidovudine—Abdominal pain—Docetaxel—skin cancer	5.86e-05	0.000698	CcSEcCtD
Zidovudine—SLC22A7—Fluoropyrimidine Activity—TP53—skin cancer	5.8e-05	0.00478	CbGpPWpGaD
Zidovudine—TK1—Metabolism—CSPG4—skin cancer	5.49e-05	0.00452	CbGpPWpGaD
Zidovudine—ABCC5—Transmembrane transport of small molecules—SLC12A2—skin cancer	5.48e-05	0.00452	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—PTCH2—skin cancer	5.47e-05	0.00451	CbGpPWpGaD
Zidovudine—SLC22A2—SLC-mediated transmembrane transport—SLC12A2—skin cancer	5.43e-05	0.00447	CbGpPWpGaD
Zidovudine—Asthenia—Docetaxel—skin cancer	5.31e-05	0.000634	CcSEcCtD
Zidovudine—Pruritus—Docetaxel—skin cancer	5.24e-05	0.000625	CcSEcCtD
Zidovudine—SLC22A11—Transmembrane transport of small molecules—SLC12A2—skin cancer	5.2e-05	0.00428	CbGpPWpGaD
Zidovudine—ABCG2—HIF-1-alpha transcription factor network—TERT—skin cancer	5.17e-05	0.00426	CbGpPWpGaD
Zidovudine—Diarrhoea—Docetaxel—skin cancer	5.07e-05	0.000604	CcSEcCtD
Zidovudine—TERT—TGF-beta Signaling Pathway—TP53—skin cancer	5.05e-05	0.00416	CbGpPWpGaD
Zidovudine—Dizziness—Docetaxel—skin cancer	4.9e-05	0.000584	CcSEcCtD
Zidovudine—SLC22A7—Transmembrane transport of small molecules—SLC12A2—skin cancer	4.72e-05	0.00388	CbGpPWpGaD
Zidovudine—Vomiting—Docetaxel—skin cancer	4.71e-05	0.000562	CcSEcCtD
Zidovudine—ABCB1—lymph node—skin cancer	4.68e-05	0.00239	CbGeAlD
Zidovudine—ABCC4—Fluoropyrimidine Activity—TP53—skin cancer	4.67e-05	0.00385	CbGpPWpGaD
Zidovudine—Rash—Docetaxel—skin cancer	4.67e-05	0.000557	CcSEcCtD
Zidovudine—Dermatitis—Docetaxel—skin cancer	4.67e-05	0.000556	CcSEcCtD
Zidovudine—Headache—Docetaxel—skin cancer	4.64e-05	0.000553	CcSEcCtD
Zidovudine—Nausea—Docetaxel—skin cancer	4.4e-05	0.000525	CcSEcCtD
Zidovudine—TERT—Signaling Pathways—GLI2—skin cancer	4.15e-05	0.00342	CbGpPWpGaD
Zidovudine—TERT—Disease—SHH—skin cancer	4.03e-05	0.00332	CbGpPWpGaD
Zidovudine—TERT—Disease—ENO2—skin cancer	4.03e-05	0.00332	CbGpPWpGaD
Zidovudine—SLC22A8—Transmembrane transport of small molecules—SLC12A2—skin cancer	3.97e-05	0.00326	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—MC1R—skin cancer	3.96e-05	0.00326	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—GLI1—skin cancer	3.9e-05	0.00321	CbGpPWpGaD
Zidovudine—TERT—Cell Cycle—CDK4—skin cancer	3.83e-05	0.00315	CbGpPWpGaD
Zidovudine—ABCC4—Transmembrane transport of small molecules—SLC12A2—skin cancer	3.8e-05	0.00313	CbGpPWpGaD
Zidovudine—TK1—Metabolism—ENO2—skin cancer	3.73e-05	0.00307	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—SUFU—skin cancer	3.7e-05	0.00304	CbGpPWpGaD
Zidovudine—ABCG2—Fluoropyrimidine Activity—TP53—skin cancer	3.43e-05	0.00282	CbGpPWpGaD
Zidovudine—ALB—SLC-mediated transmembrane transport—SLC12A2—skin cancer	3.39e-05	0.00279	CbGpPWpGaD
Zidovudine—SLC22A6—Transmembrane transport of small molecules—SLC12A2—skin cancer	3.31e-05	0.00272	CbGpPWpGaD
Zidovudine—TERT—Disease—FOXO4—skin cancer	3.28e-05	0.0027	CbGpPWpGaD
Zidovudine—CYP2A6—Fluoropyrimidine Activity—TP53—skin cancer	3.11e-05	0.00256	CbGpPWpGaD
Zidovudine—TERT—Cell Cycle—CDKN2A—skin cancer	2.92e-05	0.00241	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—SHH—skin cancer	2.82e-05	0.00232	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—RASA1—skin cancer	2.8e-05	0.00231	CbGpPWpGaD
Zidovudine—ABCB1—HIF-1-alpha transcription factor network—TERT—skin cancer	2.8e-05	0.0023	CbGpPWpGaD
Zidovudine—ABCG2—Transmembrane transport of small molecules—SLC12A2—skin cancer	2.79e-05	0.0023	CbGpPWpGaD
Zidovudine—SLC22A2—Transmembrane transport of small molecules—SLC12A2—skin cancer	2.76e-05	0.00227	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—PLIN2—skin cancer	2.71e-05	0.00223	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—SMO—skin cancer	2.67e-05	0.0022	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—PTCH1—skin cancer	2.67e-05	0.0022	CbGpPWpGaD
Zidovudine—ABCC5—Disease—CSPG4—skin cancer	2.61e-05	0.00215	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—PTGER4—skin cancer	2.6e-05	0.00214	CbGpPWpGaD
Zidovudine—CYP2C8—Arachidonic acid metabolism—PTGS2—skin cancer	2.56e-05	0.00211	CbGpPWpGaD
Zidovudine—TERT—Disease—ERCC2—skin cancer	2.34e-05	0.00193	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—FOXO4—skin cancer	2.3e-05	0.00189	CbGpPWpGaD
Zidovudine—CYP2C19—Arachidonic acid metabolism—PTGS2—skin cancer	2.29e-05	0.00188	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—skin cancer	2.19e-05	0.00181	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—CSPG4—skin cancer	2.18e-05	0.0018	CbGpPWpGaD
Zidovudine—TK1—Metabolism—ERCC2—skin cancer	2.17e-05	0.00178	CbGpPWpGaD
Zidovudine—CYP2C9—Arachidonic acid metabolism—PTGS2—skin cancer	2.09e-05	0.00172	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—skin cancer	2.08e-05	0.00171	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—PLIN2—skin cancer	2e-05	0.00164	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	1.92e-05	0.00158	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	1.91e-05	0.00157	CbGpPWpGaD
Zidovudine—ABCC5—Disease—ENO2—skin cancer	1.77e-05	0.00146	CbGpPWpGaD
Zidovudine—ABCC5—Disease—SHH—skin cancer	1.77e-05	0.00146	CbGpPWpGaD
Zidovudine—TERT—Disease—BRAF—skin cancer	1.74e-05	0.00143	CbGpPWpGaD
Zidovudine—ALB—Transmembrane transport of small molecules—SLC12A2—skin cancer	1.72e-05	0.00142	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	1.71e-05	0.00141	CbGpPWpGaD
Zidovudine—SLC22A2—Transmission across Chemical Synapses—BRAF—skin cancer	1.67e-05	0.00137	CbGpPWpGaD
Zidovudine—TERT—Cell Cycle—TP53—skin cancer	1.63e-05	0.00134	CbGpPWpGaD
Zidovudine—ALB—Selenium Micronutrient Network—PTGS2—skin cancer	1.62e-05	0.00133	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—CSPG4—skin cancer	1.61e-05	0.00133	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	1.56e-05	0.00129	CbGpPWpGaD
Zidovudine—ABCB1—Transmembrane transport of small molecules—SLC12A2—skin cancer	1.51e-05	0.00124	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—ENO2—skin cancer	1.48e-05	0.00122	CbGpPWpGaD
Zidovudine—ABCC5—Disease—FOXO4—skin cancer	1.45e-05	0.00119	CbGpPWpGaD
Zidovudine—TERT—Disease—PTGS2—skin cancer	1.4e-05	0.00115	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—PLIN2—skin cancer	1.38e-05	0.00113	CbGpPWpGaD
Zidovudine—ALB—Vitamin B12 Metabolism—IL6—skin cancer	1.37e-05	0.00113	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—PLIN2—skin cancer	1.36e-05	0.00112	CbGpPWpGaD
Zidovudine—TK1—Metabolism—PTGS2—skin cancer	1.3e-05	0.00107	CbGpPWpGaD
Zidovudine—SLC22A2—Neuronal System—BRAF—skin cancer	1.28e-05	0.00105	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—PLIN2—skin cancer	1.25e-05	0.00103	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—BRAF—skin cancer	1.22e-05	0.001	CbGpPWpGaD
Zidovudine—ALB—Folate Metabolism—TP53—skin cancer	1.21e-05	0.001	CbGpPWpGaD
Zidovudine—ALB—Folate Metabolism—IL6—skin cancer	1.11e-05	0.000915	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—CSPG4—skin cancer	1.11e-05	0.000914	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—CSPG4—skin cancer	1.1e-05	0.000905	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—ENO2—skin cancer	1.09e-05	0.000901	CbGpPWpGaD
Zidovudine—TERT—Disease—NRAS—skin cancer	1.09e-05	0.000899	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	1.07e-05	0.00088	CbGpPWpGaD
Zidovudine—ABCC5—Disease—ERCC2—skin cancer	1.03e-05	0.000848	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—CSPG4—skin cancer	1.01e-05	0.000831	CbGpPWpGaD
Zidovudine—ABCC5—Disease—TERT—skin cancer	9.65e-06	0.000795	CbGpPWpGaD
Zidovudine—TERT—Disease—KRAS—skin cancer	9.39e-06	0.000773	CbGpPWpGaD
Zidovudine—ALB—Selenium Micronutrient Network—IL6—skin cancer	8.83e-06	0.000727	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—ERCC2—skin cancer	8.62e-06	0.00071	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—PLIN2—skin cancer	8.55e-06	0.000704	CbGpPWpGaD
Zidovudine—ALB—Metabolism—PLIN2—skin cancer	8.5e-06	0.0007	CbGpPWpGaD
Zidovudine—TERT—Disease—HRAS—skin cancer	7.98e-06	0.000657	CbGpPWpGaD
Zidovudine—SLC22A2—Transmission across Chemical Synapses—HRAS—skin cancer	7.67e-06	0.000632	CbGpPWpGaD
Zidovudine—ABCC5—Disease—BRAF—skin cancer	7.64e-06	0.000629	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—NRAS—skin cancer	7.64e-06	0.000629	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	7.64e-06	0.000629	CbGpPWpGaD
Zidovudine—TERT—Disease—IL6—skin cancer	7.64e-06	0.000629	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—PLIN2—skin cancer	7.63e-06	0.000628	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—ENO2—skin cancer	7.55e-06	0.000621	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—ENO2—skin cancer	7.47e-06	0.000615	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—PLIN2—skin cancer	7.45e-06	0.000613	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—PLIN2—skin cancer	6.96e-06	0.000573	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—CSPG4—skin cancer	6.89e-06	0.000567	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—NRAS—skin cancer	6.88e-06	0.000566	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—ENO2—skin cancer	6.86e-06	0.000565	CbGpPWpGaD
Zidovudine—ALB—Metabolism—CSPG4—skin cancer	6.85e-06	0.000564	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—KRAS—skin cancer	6.58e-06	0.000542	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—ERCC2—skin cancer	6.36e-06	0.000524	CbGpPWpGaD
Zidovudine—ABCC5—Disease—PTGS2—skin cancer	6.17e-06	0.000508	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—CSPG4—skin cancer	6.15e-06	0.000506	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—CSPG4—skin cancer	6e-06	0.000494	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—KRAS—skin cancer	5.92e-06	0.000487	CbGpPWpGaD
Zidovudine—SLC22A2—Neuronal System—HRAS—skin cancer	5.88e-06	0.000484	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—TP53—skin cancer	5.85e-06	0.000481	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—CSPG4—skin cancer	5.61e-06	0.000462	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—HRAS—skin cancer	5.59e-06	0.00046	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—IL6—skin cancer	5.35e-06	0.000441	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—TP53—skin cancer	5.26e-06	0.000433	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—PTGS2—skin cancer	5.17e-06	0.000426	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	5.12e-06	0.000421	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—HRAS—skin cancer	5.03e-06	0.000414	CbGpPWpGaD
Zidovudine—ABCC5—Disease—NRAS—skin cancer	4.8e-06	0.000396	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—ENO2—skin cancer	4.68e-06	0.000386	CbGpPWpGaD
Zidovudine—ALB—Metabolism—ENO2—skin cancer	4.66e-06	0.000383	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PLIN2—skin cancer	4.59e-06	0.000378	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	4.55e-06	0.000374	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—ERCC2—skin cancer	4.38e-06	0.000361	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—ERCC2—skin cancer	4.34e-06	0.000357	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—ENO2—skin cancer	4.18e-06	0.000344	CbGpPWpGaD
Zidovudine—ABCC5—Disease—KRAS—skin cancer	4.13e-06	0.00034	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—ENO2—skin cancer	4.08e-06	0.000336	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—ERCC2—skin cancer	3.98e-06	0.000328	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—PTGS2—skin cancer	3.81e-06	0.000314	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—ENO2—skin cancer	3.81e-06	0.000314	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—CSPG4—skin cancer	3.7e-06	0.000305	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	3.66e-06	0.000302	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	3.64e-06	0.0003	CbGpPWpGaD
Zidovudine—ABCC5—Disease—HRAS—skin cancer	3.51e-06	0.000289	CbGpPWpGaD
Zidovudine—ABCC5—Disease—IL6—skin cancer	3.36e-06	0.000277	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	3.27e-06	0.000269	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—NRAS—skin cancer	3.11e-06	0.000256	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	2.98e-06	0.000245	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—ERCC2—skin cancer	2.72e-06	0.000224	CbGpPWpGaD
Zidovudine—ALB—Metabolism—ERCC2—skin cancer	2.7e-06	0.000223	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—KRAS—skin cancer	2.68e-06	0.000221	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—PTGS2—skin cancer	2.63e-06	0.000216	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—PTGS2—skin cancer	2.6e-06	0.000214	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—ENO2—skin cancer	2.51e-06	0.000207	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—ERCC2—skin cancer	2.43e-06	0.0002	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—PTGS2—skin cancer	2.39e-06	0.000197	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—TP53—skin cancer	2.38e-06	0.000196	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—ERCC2—skin cancer	2.37e-06	0.000195	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—HRAS—skin cancer	2.28e-06	0.000187	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—ERCC2—skin cancer	2.21e-06	0.000182	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—PTGS2—skin cancer	1.63e-06	0.000134	CbGpPWpGaD
Zidovudine—ALB—Metabolism—PTGS2—skin cancer	1.62e-06	0.000134	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—ERCC2—skin cancer	1.46e-06	0.00012	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—PTGS2—skin cancer	1.46e-06	0.00012	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—PTGS2—skin cancer	1.42e-06	0.000117	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—PTGS2—skin cancer	1.33e-06	0.000109	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PTGS2—skin cancer	8.76e-07	7.21e-05	CbGpPWpGaD
